Sumon Roy
Interventional Cardiology · Brockton, MANPI 1447601109
Payments from drug & device makers
What this record shows
This record is dominated by grants: $29,000 of the $44,828 with a category attached, or 64.7%. Medtronic accounts for 81.4% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2023 at $24,118 and has fallen 69.5% since, to $7,346 in 2025.
Across 282 payments — averaging $158.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$37K
- Abiomed$2K
- Abbott$2K
- Edwards Lifesciences$1K
- Novo Nordisk$413
- Novartis$385
- plus $2K from 16 others
What the payments were for
- Grants$29,00065%
- Travel & lodging$5,89513%
- Food & beverage$9,93322%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 117 | $36,503 |
| Abiomed | 25 | $2,433 |
| Abbott | 31 | $1,873 |
| Edwards Lifesciences | 17 | $1,452 |
| Novo Nordisk | 15 | $413 |
| Novartis | 20 | $385 |
| Boston Scientific | 8 | $342 |
| Pfizer | 12 | $273 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $187 |
| E.r. Squibb & Sons, L.L.C. | 7 | $169 |
| Shockwave Medical, Inc | 1 | $151 |
| Alnylam Pharmaceuticals Inc. | 7 | $143 |
| Johnson & Johnson | 1 | $118 |
| Livanova USA, Inc. | 1 | $105 |
| Amgen | 3 | $60 |
| Terumo Medical Corporation | 2 | $56 |
| W. L. Gore & Associates, Inc. | 1 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Recor Medical Inc | 1 | $25 |
| Bayer | 1 | $25 |
| Chiesi USA, Inc. | 1 | $23 |
| Scpharmaceuticals Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$44,828 in reported general payments places this provider in the 75th percentile of 128 interventional cardiology providers in Massachusetts.
See all interventional cardiology providers in Massachusetts →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 13 | $145 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Brockton
- Benoy ZachariahBrockton$9K
- Eric SecemskyBoston$1.2M
- Darshan DoshiBoston$730K
- Charles GibsonBoston$661K
- Duane PintoBoston$491K
- Robert YehBoston$412K
- Thomas PiemonteBurlington$330K
- Suzanne BaronBoston$274K
- Farouc JafferBoston$213K
- Joseph GarasicBoston$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.